-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Clinical Laboratory Predictors of Durable Response

Program: Scientific Workshops @ ASH
Session: CAR-T and Other Cellular Therapy for Mutiple Myeloma
Thursday, December 3, 2020, 9:12 AM-9:57 AM

Sandy W. Wong, MD

UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA

Disclosures: Wong: GSK: Research Funding; Sanofi: Membership on an entity's Board of Directors or advisory committees; Amgen: Consultancy; Janssen: Research Funding; Roche: Research Funding; Bristol Myers Squibb: Research Funding; Fortis: Research Funding.

See more of: CAR-T and Other Cellular Therapy for Mutiple Myeloma
See more of: Scientific Workshops @ ASH
<< Previous Presentation | Next Presentation >>